This CME-certified satellite symposium offers a retrospective review of progress in lymphoma research. This program will provide valuable clinical updates and features didactic presentations and case-driven discussions focusing on the diagnosis and treatment of historically incurable lymphomas and Waldenström’s macroglobulinemia.
Held in conjunction with the 2009 Pan Pacific Lymphoma Conference.
Program Overview
You are invited to attend a CME-certified satellite symposium offering important clinical updates and case-driven discussion focusing on the diagnosis and optimal treatment of mantle cell lymphoma, follicular lymphoma, and Waldenström’s macroglobulinemia.
Purpose
The purpose of this activity is to enhance the quality of care provided by physicians and nurses caring for patients with lymphoproliferative malignancies by providing up-to-date information on therapeutic approaches and clinical controversies.
Target Audience
This activity is designed for physicians, including hematologists and oncologists, oncology nurses, and other healthcare professionals who care for patients with mantle cell or follicular lymphomas or Waldenström’s macroglobulinemia.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe current state-of-the-art strategies for the treatment of lymphoproliferative malignancies
- Review clinical controversies in the management of mantle cell lymphoma and follicular lymphoma
- Discuss considerations regarding the role of transplantation in patients with lymphoproliferative disorders
- Evaluate novel agents and their clinical potential to expand the treatment armamentarium for mantle cell and follicular lymphomas and Waldenström’s macroglobulinemia